Cargando…
Transporter proteins knowledge graph construction and its application in drug development
Transporters are the main determinant for pharmacokinetics characteristics of drugs, such as absorption, distribution, and excretion of drugs in humans. However, it is difficult to perform drug transporter validation and structure analysis of membrane transporter proteins by experimental methods. Ma...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206172/ https://www.ncbi.nlm.nih.gov/pubmed/37235186 http://dx.doi.org/10.1016/j.csbj.2023.05.001 |
_version_ | 1785046169152389120 |
---|---|
author | Chen, Xiao-Hui Ruan, Yao Liu, Yan-Guang Duan, Xin-Ya Jiang, Feng Tang, Hao Zhang, Hong-Yu Zhang, Qing-Ye |
author_facet | Chen, Xiao-Hui Ruan, Yao Liu, Yan-Guang Duan, Xin-Ya Jiang, Feng Tang, Hao Zhang, Hong-Yu Zhang, Qing-Ye |
author_sort | Chen, Xiao-Hui |
collection | PubMed |
description | Transporters are the main determinant for pharmacokinetics characteristics of drugs, such as absorption, distribution, and excretion of drugs in humans. However, it is difficult to perform drug transporter validation and structure analysis of membrane transporter proteins by experimental methods. Many studies have demonstrated that knowledge graphs (KG) could effectively excavate potential association information between different entities. To improve the effectiveness of drug discovery, a transporter-related KG was constructed in this study. Meanwhile, a predictive frame (AutoInt_KG) and a generative frame (MolGPT_KG) were established based on the heterogeneity information obtained from the transporter-related KG by the RESCAL model. Natural product Luteolin with known transporters was selected to verify the reliability of the AutoInt_KG frame, its ROC-AUC (1:1), ROC-AUC (1:10), PR-AUC (1:1), PR-AUC (1:10) are 0.91, 0.94, 0.91 and 0.78, respectively. Subsequently, the MolGPT_KG frame was constructed to implement efficient drug design based on transporter structure. The evaluation results showed that the MolGPT_KG could generate novel and valid molecules and that these molecules were further confirmed by molecular docking analysis. The docking results showed that they could bind to important amino acids at the active site of the target transporter. Our findings will provide rich information resources and guidance for the further development of the transporter-related drugs. |
format | Online Article Text |
id | pubmed-10206172 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Research Network of Computational and Structural Biotechnology |
record_format | MEDLINE/PubMed |
spelling | pubmed-102061722023-05-25 Transporter proteins knowledge graph construction and its application in drug development Chen, Xiao-Hui Ruan, Yao Liu, Yan-Guang Duan, Xin-Ya Jiang, Feng Tang, Hao Zhang, Hong-Yu Zhang, Qing-Ye Comput Struct Biotechnol J Research Article Transporters are the main determinant for pharmacokinetics characteristics of drugs, such as absorption, distribution, and excretion of drugs in humans. However, it is difficult to perform drug transporter validation and structure analysis of membrane transporter proteins by experimental methods. Many studies have demonstrated that knowledge graphs (KG) could effectively excavate potential association information between different entities. To improve the effectiveness of drug discovery, a transporter-related KG was constructed in this study. Meanwhile, a predictive frame (AutoInt_KG) and a generative frame (MolGPT_KG) were established based on the heterogeneity information obtained from the transporter-related KG by the RESCAL model. Natural product Luteolin with known transporters was selected to verify the reliability of the AutoInt_KG frame, its ROC-AUC (1:1), ROC-AUC (1:10), PR-AUC (1:1), PR-AUC (1:10) are 0.91, 0.94, 0.91 and 0.78, respectively. Subsequently, the MolGPT_KG frame was constructed to implement efficient drug design based on transporter structure. The evaluation results showed that the MolGPT_KG could generate novel and valid molecules and that these molecules were further confirmed by molecular docking analysis. The docking results showed that they could bind to important amino acids at the active site of the target transporter. Our findings will provide rich information resources and guidance for the further development of the transporter-related drugs. Research Network of Computational and Structural Biotechnology 2023-05-03 /pmc/articles/PMC10206172/ /pubmed/37235186 http://dx.doi.org/10.1016/j.csbj.2023.05.001 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Chen, Xiao-Hui Ruan, Yao Liu, Yan-Guang Duan, Xin-Ya Jiang, Feng Tang, Hao Zhang, Hong-Yu Zhang, Qing-Ye Transporter proteins knowledge graph construction and its application in drug development |
title | Transporter proteins knowledge graph construction and its application in drug development |
title_full | Transporter proteins knowledge graph construction and its application in drug development |
title_fullStr | Transporter proteins knowledge graph construction and its application in drug development |
title_full_unstemmed | Transporter proteins knowledge graph construction and its application in drug development |
title_short | Transporter proteins knowledge graph construction and its application in drug development |
title_sort | transporter proteins knowledge graph construction and its application in drug development |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206172/ https://www.ncbi.nlm.nih.gov/pubmed/37235186 http://dx.doi.org/10.1016/j.csbj.2023.05.001 |
work_keys_str_mv | AT chenxiaohui transporterproteinsknowledgegraphconstructionanditsapplicationindrugdevelopment AT ruanyao transporterproteinsknowledgegraphconstructionanditsapplicationindrugdevelopment AT liuyanguang transporterproteinsknowledgegraphconstructionanditsapplicationindrugdevelopment AT duanxinya transporterproteinsknowledgegraphconstructionanditsapplicationindrugdevelopment AT jiangfeng transporterproteinsknowledgegraphconstructionanditsapplicationindrugdevelopment AT tanghao transporterproteinsknowledgegraphconstructionanditsapplicationindrugdevelopment AT zhanghongyu transporterproteinsknowledgegraphconstructionanditsapplicationindrugdevelopment AT zhangqingye transporterproteinsknowledgegraphconstructionanditsapplicationindrugdevelopment |